Christopher Benecchi

Insider Reports History

Location
Cambridge, MA
Signature
/s/ Brandon Marsh, attorney in fact for Christopher Benecchi
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Christopher Benecchi:

Company Role Class Num Shares Value Price $ Report Date Ownership
Sage Therapeutics, Inc. Chief Operating Officer Common Stock 0 $0 $7.79 31 Jul 2025 Direct
Sage Therapeutics, Inc. Chief Operating Officer Stock Options (Right to buy) 40,000 16 Jan 2025 Direct
Sage Therapeutics, Inc. Chief Operating Officer Stock Option (Right to Buy) 0 31 Jul 2025 Direct

Insider Reports Filed by Christopher Benecchi

Symbol Company Period Transactions Value $ Form Type Role Filing Time
SAGE Sage Therapeutics, Inc. 31 Jul 2025 4 $0 4 Chief Operating Officer 31 Jul 2025, 11:57
SAGE Sage Therapeutics, Inc. 10 Apr 2025 4 -$10,047 4 Chief Operating Officer 11 Apr 2025, 16:09
SAGE Sage Therapeutics, Inc. 13 Feb 2025 1 -$5,901 4 Chief Operating Officer 14 Feb 2025, 16:27
SAGE Sage Therapeutics, Inc. 16 Jan 2025 2 $0 4 Chief Operating Officer 21 Jan 2025, 16:11
SAGE Sage Therapeutics, Inc. 01 Nov 2024 2 $0 4 Chief Operating Officer 14 Nov 2024, 16:42
SAGE Sage Therapeutics, Inc. 05 Aug 2024 2 -$42,604 4 Chief Business Officer 07 Aug 2024, 16:04
SAGE Sage Therapeutics, Inc. 13 Feb 2024 2 $0 4 Chief Business Officer 15 Feb 2024, 17:02
SAGE Sage Therapeutics, Inc. 13 Feb 2023 1 $0 4 Chief Business Officer 15 Feb 2023, 15:46
SAGE Sage Therapeutics, Inc. 03 Feb 2023 2 -$93,575 4 Chief Business Officer 07 Feb 2023, 15:10
SAGE Sage Therapeutics, Inc. 16 Jun 2022 1 $0 4 Chief Commercial Officer 21 Jun 2022, 16:02
SAGE Sage Therapeutics, Inc. 11 Feb 2022 1 $0 4 Chief Commercial Officer 15 Feb 2022, 15:43
SAGE Sage Therapeutics, Inc. 01 Oct 2021 1 $0 4 Chief Commercial Officer 04 Oct 2021, 16:10
SAGE Sage Therapeutics, Inc. 13 Sep 2021 0 $0 3 Chief Commercial Officer 13 Sep 2021, 17:01